BrainCheck, a digital health company powering positive progress in cognitive health, has announced it has secured $13.0 million in new funding. This investment round will support the company's mission to provide comprehensive digital tools for cognitive care. The BrainCheck Platform offers a robust suite of solutions designed for proactive screening, early detection of cognitive decline, and personalized care planning, accessible anytime and anywhere.
Founded by renowned neuroscientists and technologists, including David Eagleman, PhD, BrainCheck's intuitive solutions aim to transcend the limitations of traditional cognitive assessment methods. The platform expands access to vital cognitive care with the tap of a finger, from any device, in any location. Its clinically-validated digital cognitive assessment and care planning tools are trusted by hundreds of leading providers and healthcare systems, integrating seamlessly into existing workflows, including EHR systems, to deliver actionable insights efficiently.
The $13.0 million capital infusion signifies strong investor confidence in BrainCheck's innovative approach to digital cognitive health and its market potential. The company plans to strategically deploy these funds to accelerate its growth initiatives, further enhance its platform capabilities, and expand its reach within the healthcare sector. This investment is crucial for scaling operations and continuing to meet the increasing demand for accessible and effective cognitive health solutions.
This funding round positions BrainCheck to solidify its leadership in the digital cognitive health market. The company remains committed to empowering individuals and healthcare providers with the tools necessary for earlier, better, and longer brain health. The capital will enable BrainCheck to continue its trajectory of innovation and market expansion, reinforcing its commitment to improving cognitive outcomes globally.
